Savara
SVRA
#6093
Rank
A$1.43 B
Marketcap
A$7.01
Share price
-0.79%
Change (1 day)
134.12%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2025 (TTM): -A$0.19 Billion

According to Savara's latest financial reports the company's current earnings are N/A. a decrease over its 2024 earnings that were of -A$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2025

Annual earnings

Year Earnings Change
2025 -A$0.17 Billion23.94%
2024 -A$0.14 Billion75.29%
2023 -A$76.36 Million43.38%
2022 -A$53.26 Million-11.31%
2021 -A$60.05 Million-13.3%
2020 -A$69.27 Million-36.53%
2019 -A$0.11 Billion13.76%
2018 -A$95.93 Million105.54%
2017 -A$46.68 Million34.11%
2016 -A$34.81 Million-37.43%
2015 -A$55.62 Million38.81%
2014 -A$40.07 Million33.62%
2013 -A$29.99 Million38.49%
2012 -A$21.66 Million24.59%
2011 -A$17.38 Million-36.5%
2010 -A$27.37 Million-3.14%
2009 -A$28.26 Million-23.28%
2008 -A$36.83 Million8.52%
2007 -A$33.94 Million-34.14%
2006 -A$51.54 Million184.43%
2005 -A$18.12 Million90.75%
2004 -A$9.5 Million190.35%
2003 -A$3.28 Million11.64%
2002 -A$2.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.23 Billion 34.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$25.35 Million-84.72%๐Ÿ‡บ๐Ÿ‡ธ USA